Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 541 AL 555

Alzheimer's disease and related dementias is a risk factor for lower utilization of breast cancer screening and unstaged cancer diagnosis: Observational study from SEER-Medicare 2004-2016 data

Weng X, Shen C, Vasekar M, Boltz M, Joshi M, Van Scoy LJ, Wang L.

J Geriatr Oncol. 2023 Apr;14(3):101407. doi: 10.1016/j.jgo.2022.11.006. Epub 2022 Nov 26.

Probiotic supplementation improved cognitive function in cognitively impaired and healthy older adults: a systematic review of recent trials

Handajani YS, Hengky A, Schröder-Butterfill E, Hogervorst E, Turana Y.

Neurol Sci. 2023 Apr;44(4):1163-1169. doi: 10.1007/s10072-022-06540-8. Epub 2022 Dec 19.

Omega-3 fatty acids and cognitive function

Welty FK.

Curr Opin Lipidol. 2023 Feb 1;34(1):12-21. doi: 10.1097/MOL.0000000000000862. Epub 2022 Nov 25.

Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease

Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B.

Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31.

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease Project Team.

Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.

Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers

Rouhi N, Akhgari A, Orouji N, Nezami A, Rahimzadegan M, Kamali H.

J Pharm Biomed Anal. 2023 Jan 5;222:115084. doi: 10.1016/j.jpba.2022.115084. Epub 2022 Sep 28.

Metal-organic frameworks: A promising option for the diagnosis and treatment of Alzheimer's disease

Tajahmadi S, Molavi H, Ahmadijokani F, Shamloo A, Shojaei A, Sharifzadeh M, Rezakazemi M, Fatehizadeh A, Aminabhavi TM, Arjmand M.

J Control Release. 2023 Jan;353:1-29. doi: 10.1016/j.jconrel.2022.11.002. Epub 2022 Nov 21.

Multiparametric Quantitative Imaging Biomarker as a Multivariate Descriptor of Health: A Roadmap

Raunig DL, Pennello GA, Delfino JG, Buckler AJ, Hall TJ, Guimaraes AR, Wang X, Huang EP, Barnhart HX, deSouza N, Obuchowski N.

Acad Radiol. 2023 Feb;30(2):159-182. doi: 10.1016/j.acra.2022.10.026. Epub 2022 Dec 1.

EEG coherence and power spectra during REM sleep related to melatonin intake in mild-to-moderate Alzheimer's disease: a pilot study

Cruz-Aguilar MA, Ramírez-Salado I, Hernández-González M, Guevara MA, Rivera-García AP.

Int J Neurosci. 2023 Apr;133(4):441-449. doi: 10.1080/00207454.2021.1928115. Epub 2021 Jun 1.

Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles

Mota IFL, de Lima LS, Santana BM, Gobbo GAM, Bicca JVML, Azevedo JRM, Veras LG, Taveira RAA, Pinheiro GB, Mortari MR.

Neuroscientist. 2023 Feb;29(1):78-96. doi: 10.1177/10738584211016409. Epub 2021 May 21.

Whole-plant foods and their macromolecules: untapped approaches to modulate neuroinflammation in Alzheimer's disease

Huang R, Zhu Z, Wu Q, Bekhit AEA, Wu S, Chen M, Wang J, Ding Y.

Crit Rev Food Sci Nutr. 2023;63(15):2388-2406. doi: 10.1080/10408398.2021.1975093. Epub 2021 Sep 23.

Effects and mechanisms of natural products on Alzheimer's disease

Yang Z, Zhou DD, Huang SY, Fang AP, Li HB, Zhu HL.

Crit Rev Food Sci Nutr. 2023;63(18):3168-3188. doi: 10.1080/10408398.2021.1985428. Epub 2021 Oct 6.

The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?

Diao X, Han H, Li B, Guo Z, Fu J, Wu W.

Mar Drugs. 2023 Jul 18;21(7):406. doi: 10.3390/md21070406.

The Role of Hydrogen Sulfide in Regulation of Cell Death following Neurotrauma and Related Neurodegenerative and Psychiatric Diseases

Rodkin S, Nwosu C, Sannikov A, Raevskaya M, Tushev A, Vasilieva I, Gasanov M.

Int J Mol Sci. 2023 Jun 28;24(13):10742. doi: 10.3390/ijms241310742.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias